Abstract:Background & Aims Disturbed hepatic metabolism frequently results in excessive lipid accumulation in the adipose tissue. However, the specific role of the liver–adipose axis in maintaining lipid homeostasis as well as the underlying mechanism has not yet been fully elucidated. In this study, we investigated the role of hepatic glucuronyl C5-epimerase ( Glce ) in the progression of obesity. Methods We determined the association between the expression of hepatic Glce and body mass index (BMI) in obese patients. Obesity models were established in hepatic Glce -knockout and wild-type mice fed a high-fat diet (HFD) to understand the effect of Glce on obesity development. The role of Glce in the progression of disrupted hepatokine secretion was examined via secretome analysis. Results Hepatic Glce expression was inversely correlated with BMI in obese patients. Moreover, Glce level was found to be decreased in the liver of HFD murine model. Hepatic Glce deficiency led to impaired thermogenesis in adipose tissue and exacerbated HFD-induced obesity. Interestingly, decreased level of growth differentiation factor 15 (GDF15) was observed in the culture medium of Glce -knockout mouse hepatocytes. Treatment with recombinant GDF15 obstructed obesity progression derived from the absence of hepatic Glce , similar to the effect of Glce or its inactive mutant overexpressed both in vitro and in vivo . Furthermore, liver Glce deficiency led to diminished production and increased degradation of mature GDF15, resulting in reduced hepatic GDF15 secretion. Conclusions Hepatic Glce deficiency facilitated obesity development, and decreased Glce expression further reduced hepatic secretion of GDF15, thereby perturbing lipid homeostasis in vivo . Therefore, the novel Glce –GDF15 axis plays an important role in maintaining energy balance and may act as a potential target for combating obesity. Impact and implications Evidence suggests that GDF15 plays a key role in hepatic metabolism; however, the molecular mechanism for regulating its expression and secretion is largely unknown. Our work observes that hepatic Glce , as a key Golgi-localized epimerase, may work on the maturation and post-translational regulation of GDF15. Hepatic Glce deficiency reduces the production of mature GDF15 protein and facilitates its ubiquitination, co-resulting in the aggravation of obesity development. This study may shed light on the new function and mechanism of Glce -GDF15 axis in lipid metabolism and provide a potential therapeutic target against obesity.

Hepatic glucuronyl C5-epimerase combats obesity by stabilizing GDF15

Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese mice

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature

Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A

GDF15 deficiency promotes high fat diet-induced obesity in mice

Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction

Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH

Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice

Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice.

Dual Regulation of Adipose Triglyceride Lipase by Pigment Epithelium-Derived Factor: A Novel Mechanistic Insight into Progressive Obesity

TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response

GDF15 promotes weight loss by enhancing energy expenditure in muscle

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders

Dietary obesity-induced Egr-1 in adipocytes facilitates energy storage via suppression of FOXC2

Enhanced Hexose-6-Phosphate Dehydrogenase Expression in Adipose Tissue May Contribute to Diet-Induced Visceral Adiposity

FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation

Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

Hepatic GALE Regulates Whole-Body Glucose Homeostasis by Modulating Tff3 Expression